IN-DATE
CRUS6A: Bard Crosser CTO Recanalization Catheter: S6 Peripheral, 154cm
Sign in to add this product to your favorites!
| Price: | $1,499.00 per kit |
|---|---|
| In Stock: | 0 kits |
| Expiration: | In-Date |
| Express: | Need it tomorrow? Order in next 4 hours 47 minutes and choose overnight shipping at checkout. |
We currently do not have this item in stock, but we can email you as soon as it is available.
Related Items
Additional Details
BD Bard Crosser Recanalization Catheter
Crosser® CTO Recanalization Catheters utilize high frequency, mechanical vibration to cross chronic total occlusions (CTOs) intraluminally allowing for subsequent balloon angioplasty and/or stent placement. Crosser® Catheters are available on both over-the-wire and rapid exchange delivery platforms. Crosser®CTO Catheters facilitate intraluminal placement of conventional guidewires beyond peripheral artery chronic total occlusions via atherectomy.
- Facilitates central lumen CTO recanalization via atherectomy
- Utilizes high-frequency mechanical vibration
- Frontline therapy
- Maximizes therapeutic options
AccessGUDID Info
- FDA Product Code: PDU
- FDA Product Code Name: Catheter for crossing total occlusions
- GMDN Term Code: 45188
- GMDN Term Name: Mechanical atherectomy system catheter, coronary/peripheral
- GMDN Term Description: A sterile, flexible tube (catheter) intended to be percutaneously introduced for the intraluminal mechanical disruption of atheroma plaque from the walls of both coronary and peripheral arteries (or vein grafts). It has a power-driven cutting or abrasive head for slicing/grinding the atheroma into fragments small enough to be aspirated or absorbed. This is a single-use device.
Manufacturer
C.R. Bard (a part of BD - Becton, Dickinson and Company) was a global leader in the development and manufacturing of innovative medical technologies. Known for their high-quality products, Bard specialized in solutions for vascular access, urology, oncology, and surgical specialties. Their product portfolio included catheters, biopsy devices, implantable ports, and hernia repair systems, designed to enhance patient care and procedural efficiency. As part of BD, the legacy of C.R. Bard continues to drive advancements in healthcare, delivering trusted solutions that improve outcomes for patients and providers worldwide.
